Methyl-β-cyclodextrin/paclitaxel aqueous solutions: A tool to test Cremophor-free paclitaxel

S.T.P. Pharma Sciences

Volumn 9, Issue 3, 1999, Pages 243-247

  Szente, L ^a   Vikmon, M ^a   Szeman J ^a   Otta, K ^b  

^a CycloLab Cyclodextrin Research & Development Laboratory Ltd   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Antitumour activity; Dilution stability; Methylated cyclodextrin; Paclitaxel; Stability

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALCOHOL; BETA CYCLODEXTRIN DERIVATIVE; CREMOPHOR; HEPTAKIS(2,6 O DIMETHYL) BETA CYCLODEXTRIN; METHYL BETA CYCLODEXTRIN; PACLITAXEL; SULFOPROPYLOXY BETA CYCLODEXTRIN; UNCLASSIFIED DRUG; WATER;

ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIGHT EXPOSURE; TEMPERATURE;

EID: 0032773311     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. ROWINSKY E.K., CAZENAVE L.A and DONEHOWER R.C. -Taxol, a novel investigational antimicrotubule agent. - J. Natl. Cancer Inst., 82, 1247-1259, 1990.
2. TARR B.D., SAMBANDAN T.G. and YALKOWSKY S.H. - A new parenteral emulsion for the administration of paclitaxel. - Pharm. Res., 4, 162-165, 1987.
3. ALKAN-ONYUKSEL H.A., RAMAKRISHNAN S., CHAI N.B. and PEZZUTO J. - A mixed micellar formulation suitable for the parenteral administration of paclitaxel. - Pharm. Res., 11, 206-212, 1994.
4. SHARMA A. and STRAUBINGER R.M. - Novel paclitaxel formulations: preparation and characterization of paclitaxel containing liposomes. - Pharm. Res., 11, 889-896, 1994.
5. SHEKAF. - New colorimetric assay of anticancer drug screening. -J. Natl. Canc. Inst., 82, 1107-1113, 1990.
6. MARTIN A. and CLYNES M. - Comparison of five microplate colorimetric assays for in vitro cytotoxicity and cell proliferation assays. - Cytotechnology, 11, 49-58, 1993.
7. DORDOONO S. and BURT H.N.M. - Solubility and stability of taxol: effects of buffers and cyclodextrins. - Int. J. Pharm., 133, 191-201, 1996.
8. PANCHAGNULA R. - Pharmaceutical aspects of paclitaxel. - Int. J. Pharm., 172, 1-15, 1998.
9. SHARMA U.S., SATHYMANGALAM V., BALASUBRAMIAN V. and STRAUBINGER M. - Pharmaceutical and physical properties of paclitaxel complexes in solutions with cyclodextrins. - J. Pharm. Sci., 84, 1223-1230, 1995.
10. GARAY R.P., FERAY K., FANOUS C., NAZARET M.J., VILEGAS M.F. and LETAVERNIER J.F. - Proc. 7th Int. Symp. on Cyclodextrins, Tokyo, T. Osa Ed., 25 to 28 April 1994, Business Center for Academic Societies Japan, p. 373-376.
11. UEKAMA K., HIRAYAMA F. and IRIE T. - New Trends in Cyclodextrins and Derivatives, D. Duchêne Ed., Editions de Santé, Paris, p. 414.
12. National Cancer Institute clinical brochure. - Paclitaxel NSC 125973. - Division of Cancer Treatment, National Cancer Institute, Bethesda, September 1983.
13. National Cancer Institute clinical brochure. - Paclitaxel IND 22850, NSC 125973. - Division of Cancer Treatment, National Cancer Institute, Bethesda, revised August 1990.
14. WAUNGH W.N., TRISSEL L.A. and STELLA V.J. - Stability, compatibility, and plasticizer extraction of paclitaxel (NSC-125973) injection diluted in infusion solutions and stored in various containers. - Am. J. Hosp. Pharm., 48, 1520-1524, 1991.
15. BROWN T., HAVLIN K., WEISS G., CAGNOLE J., KOELLER J. and KUHN J. - A phase I trial of paclitaxel given by a 6-hour intravenous infusion. - J. Clin. Oncol., 9, 1261-1267, 1991.
16. FJAELLSKOG M.L. - Is Cremophor EL cytotoxic? - Lancet, 342, 873, 1993.